David Jankelow

478 total citations
18 papers, 287 citations indexed

About

David Jankelow is a scholar working on Surgery, Public Health, Environmental and Occupational Health and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, David Jankelow has authored 18 papers receiving a total of 287 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Surgery, 5 papers in Public Health, Environmental and Occupational Health and 4 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in David Jankelow's work include Lipoproteins and Cardiovascular Health (6 papers), Streptococcal Infections and Treatments (5 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (4 papers). David Jankelow is often cited by papers focused on Lipoproteins and Cardiovascular Health (6 papers), Streptococcal Infections and Treatments (5 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (4 papers). David Jankelow collaborates with scholars based in South Africa, Czechia and United States. David Jankelow's co-authors include Madeleine W. Cunningham, Stanley D. Kosanke, Carlos M.G. Durán, Colin Schamroth, Dirk Blom, Marja‐Riitta Taskinen, Frederick J. Raal, A A Wadee, Z. HAFFEJEE and Kumarasen Cooper and has published in prestigious journals such as SHILAP Revista de lepidopterología, CHEST Journal and The Journal of Infectious Diseases.

In The Last Decade

David Jankelow

17 papers receiving 279 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Jankelow South Africa 7 155 65 61 56 52 18 287
Robert Marchand Canada 7 61 0.4× 113 1.7× 12 0.2× 65 1.2× 109 2.1× 10 347
M.A.K. Rumi Bangladesh 8 49 0.3× 25 0.4× 22 0.4× 32 0.6× 139 2.7× 15 365
Hye Ok Kim South Korea 14 253 1.6× 42 0.6× 10 0.2× 22 0.4× 30 0.6× 34 489
Lynda Bererhi France 8 74 0.5× 162 2.5× 49 0.8× 32 0.6× 52 1.0× 13 381
Julie Wright Canada 10 98 0.6× 56 0.9× 17 0.3× 44 0.8× 90 1.7× 18 394
Anna Faura Spain 11 36 0.2× 69 1.1× 17 0.3× 33 0.6× 53 1.0× 26 389
Oksana Boyarchuk Ukraine 11 56 0.4× 82 1.3× 8 0.1× 95 1.7× 61 1.2× 103 362
Jorge Morales Spain 12 62 0.4× 15 0.2× 21 0.3× 39 0.7× 33 0.6× 41 283
Vignesh Chidambaram United States 11 54 0.3× 142 2.2× 51 0.8× 31 0.6× 53 1.0× 21 338
Brent Muhlestein United States 4 26 0.2× 26 0.4× 241 4.0× 56 1.0× 79 1.5× 5 408

Countries citing papers authored by David Jankelow

Since Specialization
Citations

This map shows the geographic impact of David Jankelow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Jankelow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Jankelow more than expected).

Fields of papers citing papers by David Jankelow

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Jankelow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Jankelow. The network helps show where David Jankelow may publish in the future.

Co-authorship network of co-authors of David Jankelow

This figure shows the co-authorship network connecting the top 25 collaborators of David Jankelow. A scholar is included among the top collaborators of David Jankelow based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Jankelow. David Jankelow is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Kirvan, Christine A., Susan E. Swedo, Harry R. Hill, et al.. (2023). IgG2 rules: N-acetyl-β-D-glucosamine-specific IgG2 and Th17/Th1 cooperation may promote the pathogenesis of acute rheumatic heart disease and be a biomarker of the autoimmune sequelae of Streptococcus pyogenes. Frontiers in Cardiovascular Medicine. 9. 919700–919700. 10 indexed citations
2.
Jankelow, David. (2021). A Masterclass. 18(3).
3.
Jacobson, Barry, Elise Schapkaitz, Susan Louw, et al.. (2021). Recommendations for the diagnosis and management of vaccine-induced immune thrombotic thrombocytopenia.. PubMed. 111(6). 535–537. 4 indexed citations
4.
Zühlke, Liesl, Karen Sliwa, Pamela Naidoo, et al.. (2019). Cardiovascular medicine and research in sub-Saharan Africa: challenges and opportunities. Nature Reviews Cardiology. 16(11). 642–644. 6 indexed citations
5.
Jankelow, David, Blanche Cupido, Liesl Zühlke, et al.. (2018). Prevention of infective endocarditis associated with dental interventions. 73(2). 94–97. 2 indexed citations
6.
Jankelow, David, Blanche Cupido, Liesl Zühlke, et al.. (2017). Prevention of infective endocarditis associated with dental interventions: South African Heart Association position statement, endorsed by the South African Dental Association. SHILAP Revista de lepidopterología. 14(3). 4 indexed citations
7.
Raal, Frederick J., Marja‐Riitta Taskinen, Colin Schamroth, et al.. (2015). South African Dyslipidaemia Guideline Consensus Statement. SHILAP Revista de lepidopterología. 57(2). 9–9. 2 indexed citations
8.
Raal, Frederick J., et al.. (2013). South African Dyslipidaemia Guideline Consensus Statement. SHILAP Revista de lepidopterología. 55(1). 9–18. 9 indexed citations
9.
Raal, Frederick J., et al.. (2012). South African dyslipidaemia guideline consensus statement. The Egyptian Heart Journal. 9(2). 106–117. 1 indexed citations
10.
Raal, Frederick J., et al.. (2012). South African Dyslipidaemia Guideline Consensus Statement:. Journal of Endocrinology Metabolism and Diabetes of South Africa. 17(3). 155–165. 63 indexed citations
11.
Kosanke, Stanley D., et al.. (2001). Pathogenic Mechanisms in Rheumatic Carditis: Focus on Valvular Endothelium. The Journal of Infectious Diseases. 183(3). 507–511. 128 indexed citations
12.
HAFFEJEE, Z., et al.. (1997). Rheumatic Aschoff nodules revisited. II: Cytokine expression corroborates recently proposed sequential stages. Histopathology. 31(5). 460–464. 26 indexed citations
13.
Smith, David H.G., et al.. (1991). A comparative study of atenolol, nifedipine and their combination in the treatment of hypertension.. PubMed. 79(1). 12–5. 7 indexed citations
14.
Kallenbach, J, Vanessa R. Panz, David Jankelow, Barry I. Joffe, & H C Seftel. (1990). Metabolic and Hormonal Responses to Salbutamol in Asthma. Evidence of Beta-Adrenergic Overactivity?. Respiration. 57(1). 21–27. 3 indexed citations
15.
Jankelow, David, et al.. (1990). Safety, tolerability and efficacy of acipimox in type II hyperlipidaemia.. PubMed. 77(10). 504–5. 1 indexed citations
16.
NEUTEL, J, et al.. (1990). The aeromedical implications of atrial fibrillation.. PubMed. 61(11). 1036–8. 1 indexed citations
17.
Jankelow, David, et al.. (1990). Bezafibrate and simvastatin (MK-733) in the treatment of primary hypercholesterolaemia.. South African Medical Journal. 77(10). 500–3. 5 indexed citations
18.
Kallenbach, J, Vanessa R. Panz, B. I. Joffe, et al.. (1988). Nocturnal Events Related to “Morning Dipping” in Bronchial Asthma. CHEST Journal. 93(4). 751–757. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026